Dual-Loop Risk-Oriented Process–Outcome Conceptual Model of Digital Enablement for Enterprise Innovation Development Management
Economic journal Odessa polytechnic university · 13.05.2026 · 2 (36) · 164-172
DOI: 10.15276/ej.02.2026.18 ↗Kurz gefasst
Fachartikel in der Zeitschrift Economic journal Odessa polytechnic university, online erschienen am 13.05.2026. Verfasst von Andrii Lozan.
Abstract (Originalsprache)
The article substantiates the conceptual foundations of digital support for managing enterprise innovation development in a global risk environment. A dual-loop risk-oriented process–outcome model is proposed, combining process and outcome loops with crosscutting digital support and continuous risk-oriented management support. The process loop covers opportunity and risk identification, idea generation and selection, innovation creation, implementation, diffusion and assimilation. The outcome loop captures multidimensional effects of innovation development. Feedback transforms achieved outcomes into renewed innovation potential and an input for the next innovation-development cycle. It specifies how data, analytics, monitoring, communication and cybersecurity support managerial decisions.
Zitieren
APA
Lozan, A. (2026). Dual-Loop Risk-Oriented Process–Outcome Conceptual Model of Digital Enablement for Enterprise Innovation Development Management. Economic journal Odessa polytechnic university, 2(36), 164-172. https://doi.org/10.15276/ej.02.2026.18
Vancouver
Lozan A. Dual-Loop Risk-Oriented Process–Outcome Conceptual Model of Digital Enablement for Enterprise Innovation Development Management. Economic journal Odessa polytechnic university. 2026;2(36):164-172. doi:10.15276/ej.02.2026.18
BibTeX
@article{Lozan2026,
author = {Lozan, Andrii},
title = {Dual-Loop Risk-Oriented Process–Outcome Conceptual Model of Digital Enablement for Enterprise Innovation Development Management},
journal = {Economic journal Odessa polytechnic university},
year = {2026},
volume = {2},
number = {36},
pages = {164--172},
doi = {10.15276/ej.02.2026.18}
}
EUVIMED